FindTrial
Sign In

ASSESSMENT OF AWAKENING FROM ANAESTHESIA FOLLOWING SUGAMMADEX ADMINISTRATION AS A REVERSAL AGENT

An Observational Study on Emergence from Anaesthesia in Adults Following Sugammadex Administration as a Neuromuscular Blockade Reversal Agent - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097066
Enrollment
52
Registered
2025-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Intervention5: Nil: Nil Intervention6: Nil: Nil

Sponsors

K S HEGDE MEDICAL ACADEMY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18-60 years ASA-PS I and II Expected surgical duration less than 3 hours Patients undergoing elective surgeries

Exclusion criteria

Exclusion criteria: 1.Patient who cannot comprehend, uncooperative patient 2.Neuropsychiatric disease 3.Chronic alcohol or drug addict 4.Planned postoperative ICU Admission

Design outcomes

Primary

MeasureTime frame
To compare recovery status in the postoperative period following reversal from general anaesthesia using Sugammadex and Neostigmine, using 1.AVPU scale 2.six screener test 3.MiniCog testTimepoint: To compare recovery status in the postoperative period following reversal from general anaesthesia using Sugammadex and Neostigmine, using 1.AVPU scale 2.six screener test 3.MiniCog test—

Secondary

MeasureTime frame
NILTimepoint: Nil—

Countries

India

Contacts

Public ContactDR M Venkat karli

K S Hegde Medical Academy

muralishankarbhat@gmail.com8884537753

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026